Acquisition Momentum Maetrics has been acquired by RQM+ and now operates under the combined brand and leadership trajectory, signaling an integration phase with potential cross-sell opportunities into RQM+’s broader MedTech services and client network.

PMCF Synergy Recent and upcoming collaborations between RQM+ and 3Aware for post-market surveillance and real-world evidence platforms present a clear channel to offer unified regulatory and PMCF support solutions to MedTech manufacturers seeking cost and time efficiencies.

Tech Stack Leverage Maetrics and RQM+ clients frequently use tools like Tableau, iCIMS, HubSpot, and SOLIDWORKS; there is opportunity to position integrated data analytics, CRM-driven marketing, and design-to-regulatory workflow optimization services to optimize product development and regulatory submissions.

Growth Footprint With revenue in the mid-range biotech services band and a mid-sized employee base, there is potential to upsell larger scope programs such as end-to-end regulatory programs, post-market strategies, and expanded consulting engagements to similar peer firms within the MedTech ecosystem.

Leadership & Expansion New CEO appointment and leadership moves in 2024 2025 indicate an active growth strategy; position targeted executive outreach around strategic partnerships, mergers and acquisitions advisory, and scalable regulatory programs to align with RQM+ expansion.